Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$37.89

6.63 (21.21%)

07:54
01/11/17
01/11
07:54
01/11/17
07:54

Sarepta EXONDYS 51 launch encouraging, says RBC Capital

RBC Capital analyst Simos Simeonidis notes that Sarepta reported that it only obtained revenue of $5.4M from its EXONDYS 51 in the wake of its launch. However, the analyst is "encouraged by the disclosure that 250 forms have been filled out for patients whose mutation status has been verified" as of the end of last year. Simeonidis continues to predict that the drug will undergo a "slow and gradual ramp," with its sales accelerating significantly in the "later" quarters of this year. The analyst keeps a $98 price target and an Outperform rating on the stock.

SRPT Sarepta
$37.89

6.63 (21.21%)

01/06/17
JMPS
01/06/17
NO CHANGE
Target $65
JMPS
Outperform
Sarepta price target lowered to $65 after physician survey at JMP Securities
JMP Securities analyst Liisa Bayko reported the firm conducted its first survey of U.S. physicians who treat Duchenne muscular dystrophy patients to gauge early experiences with Sarepta's Exondys 51. At the end of 2016, respondents had written a prescription to about 1 in 5 eligible patients, 1 in 5 were denied coverage and about 15% were in the adjudication process, noted Bayko, who lowered her price target on Sarepta to $65 from $90 to adjust for the survey results as well as an updated pricing analysis. Bayko keeps an Outperform rating on Sarepta and said she sees potential upside to about $160 per share if Exondys 51 is approved in the EU and if all of its earlier-stage assets targeting exons 45/53 are successful.
01/10/17
BARD
01/10/17
NO CHANGE
Target $102
BARD
Outperform
Baird expects Sarepta 'relief rally' on launch update
Baird analyst Brian Skorney expects a "relief rally" in shares of Sarepta Therapeutics after the company announced Exondys 51 sales of $5.4M and greater than 250 patient start forms were submitted by year-end. If the shares were at $60, the sales figure would be a disappointment, but expectations have been lowered and whisper numbers were nearing negative territory, Skorney tells investors in a research note following Sarepta's JPMorgan Conference presentation. "This is just the beginning," as the company has dystrophin data coming from SRP-4053 in exon-53-amenable patients in the first half of 2017 and data plans to advance at least three additional assets, the analyst contends. Skorney keeps an Outperform rating on Sarepta with a $102 price target.
01/10/17
LEER
01/10/17
NO CHANGE
LEER
Market Perform
Leerink discusses discrepancy between Sarepta revenue, start forms
Leerink analyst Joseph Schwartz says that for Sarepta Therapeutics to meet the Q4 revenue estimate of $6.0M, he anticipated a greater than 200 start form number. The company, however, reported $5.4M in sales despite a start form number of over 250. The discrepancy between start forms and the revenue miss could be due to several factors, including the translatability of start forms to reimbursed written prescriptions and patient demographics, Schwartz tells investors in a research note. Continued push-back from payors that limit reimbursement could render the start form number inaccurate, he contends. The analyst views today's numbers from Sarepta as "encouraging," but sees room for improvement. Schwartz keeps a Market Perform rating on the shares.
01/10/17
PIPR
01/10/17
NO CHANGE
Target $68
PIPR
Overweight
Piper says Sarepta Q4 sales topped estimate
Piper Jaffray analyst Edward Tenthoff says Sarepta Therapeutics' Q4 Exondys 51 sales of $5.4M beat his estimate of $4.5M. The company is making good progress on reimbursement and expects payor conversions to accelerate in Q2, Tenthoff tells investors in a research note. He estimates U.S. Exondys 51 sales of $274M in 2017 with peak U.S. sales of greater than $500M. Tenthoff reiterates an Overweight rating on Sarepta with a $68 price target.

TODAY'S FREE FLY STORIES

02:40
01/18/17
01/18
02:40
01/18/17
02:40
General news
FX Update: The dollar recouped some of yesterday's lost ground »

FX Update: The dollar…

C

Citi

$58.38

-1.25 (-2.10%)

, GS

Goldman Sachs

$235.74

-8.56 (-3.50%)

20:25
01/17/17
01/17
20:25
01/17/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

C

Citi

$58.38

-1.25 (-2.10%)

GS

Goldman Sachs

$235.74

-8.56 (-3.50%)

USB

U.S. Bancorp

$50.31

-1.38 (-2.67%)

AMTD

TD Ameritrade

$45.87

-0.99 (-2.11%)

NTRS

Northern Trust

$88.15

-2.04 (-2.26%)

FAST

Fastenal

$48.26

0.205 (0.43%)

CBSH

Commerce Bancshares

$55.90

-2.02 (-3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 25

    Jan

  • 26

    Jan

  • 15

    Mar

TOSBF

Toshiba, also use TOSYY

$2.60

0.094709 (3.77%)

, TOSYY

Toshiba, also use TOSBF

$15.35

0.37 (2.47%)

20:05
01/17/17
01/17
20:05
01/17/17
20:05
Periodicals
Toshiba says considers spinoff of memory chip unit, Bloomberg reports »

Toshiba (TOSBF) is…

TOSBF

Toshiba, also use TOSYY

$2.60

0.094709 (3.77%)

TOSYY

Toshiba, also use TOSBF

$15.35

0.37 (2.47%)

WDC

Western Digital

$71.62

0.62 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

TM

Toyota

$118.41

-1.4 (-1.17%)

, AIQUY

Air Liquide

$21.97

-0.245 (-1.10%)

19:56
01/17/17
01/17
19:56
01/17/17
19:56
Hot Stocks
Thirteen energy, transport, industrial companies launch 'Hydrogen Council' »

Toyota (TM) announced…

TM

Toyota

$118.41

-1.4 (-1.17%)

AIQUY

Air Liquide

$21.97

-0.245 (-1.10%)

ALSMY

Alstom

NGLOY

Anglo American

$8.14

0.1 (1.24%)

BAMXY

BMW Group

DDAIF

Daimler AG

$75.35

-0.24 (-0.32%)

HMC

Honda

$29.66

-0.42 (-1.40%)

HYMLF

Hyundai Motor Co

RDS.A

Royal Dutch Shell

$55.54

0.06 (0.11%)

RDS.B

Royal Dutch Shell

$58.91

0.24 (0.41%)

LNAGF

Linde AG

$161.90

-0.15 (-0.09%)

TOT

Total

$51.51

-0.08 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

NYT

New York Times

$13.50

-0.1 (-0.74%)

19:30
01/17/17
01/17
19:30
01/17/17
19:30
Hot Stocks
New York Times releases internal report on newsroom strategy »

The New York Times has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENRJ

EnerJex Resources

19:19
01/17/17
01/17
19:19
01/17/17
19:19
Hot Stocks
EnerJex announces NYSE acceptance of plan to meet listing standards »

EnerJex Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$235.74

-8.56 (-3.50%)

19:19
01/17/17
01/17
19:19
01/17/17
19:19
Periodicals
Goldman Sachs compliance chief to step down, Reuters says »

Goldman Sachs compliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$16.96

-0.29 (-1.68%)

19:13
01/17/17
01/17
19:13
01/17/17
19:13
Periodicals
Twitter phases out 'buy' button, TechCrunch says »

Twitter appears to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

HSBC

HSBC

$41.18

0.02 (0.05%)

19:04
01/17/17
01/17
19:04
01/17/17
19:04
Periodicals
HSBC CEO: Trading ops generating 20% of London revenue may move, Bloomberg says »

HSBC CEO Stuart Gulliver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$41.18

0.02 (0.05%)

19:02
01/17/17
01/17
19:02
01/17/17
19:02
Periodicals
HSBC CEO: 10% RoE may be new goal, Bloomberg says »

HSBC CEO Stuart Gulliver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWT

California Water Service

$33.05

0.05 (0.15%)

19:01
01/17/17
01/17
19:01
01/17/17
19:01
Initiation
California Water Service initiated  »

California Water Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWK

American Water

$72.07

1.25 (1.77%)

19:01
01/17/17
01/17
19:01
01/17/17
19:01
Initiation
American Water initiated  »

American Water initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.60

0.094709 (3.77%)

, TOSYY

Toshiba, also use TOSBF

$15.35

0.37 (2.47%)

18:59
01/17/17
01/17
18:59
01/17/17
18:59
Periodicals
Toshiba: Considering spinning off chip unit, Bloomberg reports »

Responding to a Nikkei…

TOSBF

Toshiba, also use TOSYY

$2.60

0.094709 (3.77%)

TOSYY

Toshiba, also use TOSBF

$15.35

0.37 (2.47%)

WDC

Western Digital

$71.62

0.62 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

KSU

Kansas City Southern

18:57
01/17/17
01/17
18:57
01/17/17
18:57
Initiation
Kansas City Southern initiated  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

NSC

Norfolk Southern

$108.90

-2.69 (-2.41%)

18:57
01/17/17
01/17
18:57
01/17/17
18:57
Initiation
Norfolk Southern initiated  »

Norfolk Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

UNP

Union Pacific

$103.37

-1.88 (-1.79%)

18:57
01/17/17
01/17
18:57
01/17/17
18:57
Initiation
Union Pacific initiated  »

Union Pacific initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 09

    May

AZO

AutoZone

$782.29

2.48 (0.32%)

18:54
01/17/17
01/17
18:54
01/17/17
18:54
Initiation
AutoZone initiated  »

AutoZone initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORLY

O'Reilly Automotive

$278.76

-0.39 (-0.14%)

18:54
01/17/17
01/17
18:54
01/17/17
18:54
Initiation
O'Reilly Automotive initiated  »

O'Reilly Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

AAP

Advance Auto Parts

$173.00

-1.79 (-1.02%)

18:54
01/17/17
01/17
18:54
01/17/17
18:54
Initiation
Advance Auto Parts initiated  »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTE

Earthstone Energy

$13.40

-0.18 (-1.33%)

18:51
01/17/17
01/17
18:51
01/17/17
18:51
Initiation
Earthstone Energy initiated  »

Earthstone Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.43

1.25 (0.85%)

18:41
01/17/17
01/17
18:41
01/17/17
18:41
Upgrade
McKesson rating change  »

McKesson upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

NRG

NRG Energy

$15.34

0.74 (5.07%)

18:38
01/17/17
01/17
18:38
01/17/17
18:38
Hot Stocks
NRG Energy says 'looks forward to an open dialogue with Elliott and Bluescape' »

NRG Energy received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LMCA

Liberty Media

$28.71

-1.53 (-5.06%)

, LMCK

Liberty Media

$28.72

-1.54 (-5.09%)

18:22
01/17/17
01/17
18:22
01/17/17
18:22
Hot Stocks
Liberty Media holders approve proposals relating to acquisition of Formula 1 »

Liberty Media announced…

LMCA

Liberty Media

$28.71

-1.53 (-5.06%)

LMCK

Liberty Media

$28.72

-1.54 (-5.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

AUY

Yamana Gold

$3.26

0.09 (2.84%)

18:17
01/17/17
01/17
18:17
01/17/17
18:17
Hot Stocks
Yamana Gold announces resumption of operations at El Penon Mine in Chile »

Yamana Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCJ

Cameco

$13.27

-0.02 (-0.15%)

18:14
01/17/17
01/17
18:14
01/17/17
18:14
Hot Stocks
Cameco down 9.5% after announcing FY16 results will be lower than expected »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.